CX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cemex SAB de CV (CX) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock is currently experiencing a downward trend, with technical indicators showing bearish momentum. Additionally, the company's financial performance in the latest quarter shows a significant decline in net income, despite revenue growth. Analyst ratings are mixed, with some downgrades and balanced risk/reward commentary. There are no strong positive catalysts or proprietary trading signals to suggest an immediate buying opportunity.
The stock is in a bearish trend with a -5.03% regular market change. The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 30.549, and moving averages are converging, suggesting no clear trend reversal. Key support is at 11.207, and the stock is trading near this level, with resistance at 12.796.
The company has declared a quarterly dividend of $0.0225 per share, which may appeal to dividend-focused investors. Revenue increased by 9.66% YoY in Q4 2025, indicating some growth in operations.
Net income dropped significantly by -835.93% YoY in Q4 2025, and EPS remains negative. Analysts have issued mixed ratings, with recent downgrades citing balanced risk/reward and valuation concerns. The stock has a high probability of further declines in the short term based on historical candlestick patterns.
In Q4 2025, revenue increased by 9.66% YoY to $4.18 billion, but net income dropped significantly to -$355.52 million, reflecting an -835.93% YoY decline. EPS remained negative at -0.02, with gross margin improving slightly to 32.6%.
Analyst ratings are mixed. JPMorgan and Scotiabank raised price targets recently, citing transformation and growth potential. However, HSBC downgraded the stock, citing balanced risk/reward and valuation concerns. The average price target is around $13-$14, slightly above the current price but not significantly compelling for a long-term buy.
